drugset / Trial / NCT01001364

A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with Asthma

NCT01001364

Phase 3 Completed 88 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study primary objective is to compare the impact of two products containing budesonide and formoterol as individual capsules with inhalation powder for the pulmonary function of subjects with persistent asthma.

Timeline

Start
2010-02
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 200 ug Inhaled
Comparator Formoterol Other / unclassified 12 ug Inhaled

Indications